nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.139	0.263	CbGbCtD
Amsacrine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.139	0.263	CbGbCtD
Amsacrine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.124	0.234	CbGbCtD
Amsacrine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0655	0.124	CbGbCtD
Amsacrine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0619	0.117	CbGbCtD
Amsacrine—NCOA3—FOXA1 transcription factor network—SCGB1A1—chronic obstructive pulmonary disease	0.0122	0.148	CbGpPWpGaD
Amsacrine—NCOA3—FOXA1 transcription factor network—SFTPD—chronic obstructive pulmonary disease	0.00924	0.112	CbGpPWpGaD
Amsacrine—NCOA3—respiratory system—chronic obstructive pulmonary disease	0.00741	0.169	CbGeAlD
Amsacrine—NCOA3—connective tissue—chronic obstructive pulmonary disease	0.00653	0.149	CbGeAlD
Amsacrine—NCOA3—bronchus—chronic obstructive pulmonary disease	0.0061	0.139	CbGeAlD
Amsacrine—NCOA3—smooth muscle tissue—chronic obstructive pulmonary disease	0.00597	0.136	CbGeAlD
Amsacrine—TOP2A—Salmeterol—Salbutamol—chronic obstructive pulmonary disease	0.00587	0.807	CbGdCrCtD
Amsacrine—NCOA3—trachea—chronic obstructive pulmonary disease	0.00548	0.125	CbGeAlD
Amsacrine—NCOA3—FOXA1 transcription factor network—SERPINA1—chronic obstructive pulmonary disease	0.00499	0.0604	CbGpPWpGaD
Amsacrine—NCOA3—lung—chronic obstructive pulmonary disease	0.00394	0.09	CbGeAlD
Amsacrine—TOP2A—bronchus—chronic obstructive pulmonary disease	0.00358	0.0818	CbGeAlD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—chronic obstructive pulmonary disease	0.00249	0.0301	CbGpPWpGaD
Amsacrine—TOP2A—lung—chronic obstructive pulmonary disease	0.00231	0.0528	CbGeAlD
Amsacrine—NCOA3—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.002	0.0242	CbGpPWpGaD
Amsacrine—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.00196	0.0237	CbGpPWpGaD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—LEP—chronic obstructive pulmonary disease	0.00155	0.0187	CbGpPWpGaD
Amsacrine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00148	0.00438	CcSEcCtD
Amsacrine—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.00145	0.00431	CcSEcCtD
Amsacrine—Infestation—Montelukast—chronic obstructive pulmonary disease	0.00145	0.00431	CcSEcCtD
Amsacrine—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.00145	0.00429	CcSEcCtD
Amsacrine—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00144	0.00427	CcSEcCtD
Amsacrine—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00421	CcSEcCtD
Amsacrine—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00142	0.0042	CcSEcCtD
Amsacrine—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.0042	CcSEcCtD
Amsacrine—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.00138	0.00408	CcSEcCtD
Amsacrine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00138	0.00408	CcSEcCtD
Amsacrine—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00405	CcSEcCtD
Amsacrine—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00405	CcSEcCtD
Amsacrine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00136	0.00402	CcSEcCtD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.00135	0.0163	CbGpPWpGaD
Amsacrine—NCOA3—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.00134	0.0162	CbGpPWpGaD
Amsacrine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00134	0.00397	CcSEcCtD
Amsacrine—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00397	CcSEcCtD
Amsacrine—Necrosis—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00395	CcSEcCtD
Amsacrine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00132	0.00392	CcSEcCtD
Amsacrine—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.0039	CcSEcCtD
Amsacrine—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.00132	0.0039	CcSEcCtD
Amsacrine—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.00131	0.0159	CbGpPWpGaD
Amsacrine—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00389	CcSEcCtD
Amsacrine—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00389	CcSEcCtD
Amsacrine—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00388	CcSEcCtD
Amsacrine—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00388	CcSEcCtD
Amsacrine—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00387	CcSEcCtD
Amsacrine—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.0013	0.00385	CcSEcCtD
Amsacrine—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00382	CcSEcCtD
Amsacrine—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00381	CcSEcCtD
Amsacrine—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00128	0.0038	CcSEcCtD
Amsacrine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00128	0.00379	CcSEcCtD
Amsacrine—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00375	CcSEcCtD
Amsacrine—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00373	CcSEcCtD
Amsacrine—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00371	CcSEcCtD
Amsacrine—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00369	CcSEcCtD
Amsacrine—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00367	CcSEcCtD
Amsacrine—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00367	CcSEcCtD
Amsacrine—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00367	CcSEcCtD
Amsacrine—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00124	0.00367	CcSEcCtD
Amsacrine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00123	0.00366	CcSEcCtD
Amsacrine—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00366	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.00361	CcSEcCtD
Amsacrine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.0036	CcSEcCtD
Amsacrine—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00121	0.00359	CcSEcCtD
Amsacrine—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00356	CcSEcCtD
Amsacrine—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00356	CcSEcCtD
Amsacrine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00119	0.00353	CcSEcCtD
Amsacrine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00119	0.00353	CcSEcCtD
Amsacrine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00119	0.00352	CcSEcCtD
Amsacrine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00119	0.00352	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00118	0.0142	CbGpPWpGaD
Amsacrine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00349	CcSEcCtD
Amsacrine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.00349	CcSEcCtD
Amsacrine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.00349	CcSEcCtD
Amsacrine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00117	0.0142	CbGpPWpGaD
Amsacrine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.00347	CcSEcCtD
Amsacrine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00347	CcSEcCtD
Amsacrine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00346	CcSEcCtD
Amsacrine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00346	CcSEcCtD
Amsacrine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00117	0.00346	CcSEcCtD
Amsacrine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.00345	CcSEcCtD
Amsacrine—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00344	CcSEcCtD
Amsacrine—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00344	CcSEcCtD
Amsacrine—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.00115	0.00341	CcSEcCtD
Amsacrine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.0034	CcSEcCtD
Amsacrine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00339	CcSEcCtD
Amsacrine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00339	CcSEcCtD
Amsacrine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00338	CcSEcCtD
Amsacrine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00336	CcSEcCtD
Amsacrine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00334	CcSEcCtD
Amsacrine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00111	0.00329	CcSEcCtD
Amsacrine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00327	CcSEcCtD
Amsacrine—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00325	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00109	0.0132	CbGpPWpGaD
Amsacrine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00321	CcSEcCtD
Amsacrine—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.00107	0.0244	CbGeAlD
Amsacrine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00313	CcSEcCtD
Amsacrine—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00305	CcSEcCtD
Amsacrine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00102	0.00302	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00101	0.00301	CcSEcCtD
Amsacrine—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000989	0.00293	CcSEcCtD
Amsacrine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000989	0.00293	CcSEcCtD
Amsacrine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000985	0.00292	CcSEcCtD
Amsacrine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000984	0.00292	CcSEcCtD
Amsacrine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000984	0.00292	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000981	0.00291	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000981	0.00291	CcSEcCtD
Amsacrine—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000981	0.0119	CbGpPWpGaD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000961	0.00285	CcSEcCtD
Amsacrine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00096	0.00285	CcSEcCtD
Amsacrine—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000944	0.0114	CbGpPWpGaD
Amsacrine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000941	0.00279	CcSEcCtD
Amsacrine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000941	0.00279	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000933	0.0113	CbGpPWpGaD
Amsacrine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000932	0.00277	CcSEcCtD
Amsacrine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000928	0.00275	CcSEcCtD
Amsacrine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000925	0.00274	CcSEcCtD
Amsacrine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000925	0.00274	CcSEcCtD
Amsacrine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000922	0.00273	CcSEcCtD
Amsacrine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00092	0.00273	CcSEcCtD
Amsacrine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00092	0.00273	CcSEcCtD
Amsacrine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000917	0.00272	CcSEcCtD
Amsacrine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000908	0.00269	CcSEcCtD
Amsacrine—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000907	0.00269	CcSEcCtD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000904	0.0109	CbGpPWpGaD
Amsacrine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000901	0.00267	CcSEcCtD
Amsacrine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000889	0.00264	CcSEcCtD
Amsacrine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000885	0.00263	CcSEcCtD
Amsacrine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000885	0.00263	CcSEcCtD
Amsacrine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000873	0.00259	CcSEcCtD
Amsacrine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000869	0.00258	CcSEcCtD
Amsacrine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000865	0.00256	CcSEcCtD
Amsacrine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000853	0.00253	CcSEcCtD
Amsacrine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000852	0.0103	CbGpPWpGaD
Amsacrine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000852	0.00253	CcSEcCtD
Amsacrine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000848	0.00251	CcSEcCtD
Amsacrine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000845	0.0025	CcSEcCtD
Amsacrine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000845	0.0025	CcSEcCtD
Amsacrine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000836	0.00248	CcSEcCtD
Amsacrine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000836	0.00248	CcSEcCtD
Amsacrine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000833	0.00247	CcSEcCtD
Amsacrine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000823	0.00244	CcSEcCtD
Amsacrine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000821	0.00243	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000818	0.00243	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000818	0.00243	CcSEcCtD
Amsacrine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000817	0.00242	CcSEcCtD
Amsacrine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000817	0.00242	CcSEcCtD
Amsacrine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00081	0.0024	CcSEcCtD
Amsacrine—Pain—Formoterol—chronic obstructive pulmonary disease	0.00081	0.0024	CcSEcCtD
Amsacrine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000803	0.00238	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000801	0.00238	CcSEcCtD
Amsacrine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.0008	0.00237	CcSEcCtD
Amsacrine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000797	0.00236	CcSEcCtD
Amsacrine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000793	0.00235	CcSEcCtD
Amsacrine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000791	0.00235	CcSEcCtD
Amsacrine—ABCB1—trachea—chronic obstructive pulmonary disease	0.00079	0.0181	CbGeAlD
Amsacrine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000787	0.00233	CcSEcCtD
Amsacrine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000785	0.00233	CcSEcCtD
Amsacrine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000784	0.00233	CcSEcCtD
Amsacrine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000781	0.00231	CcSEcCtD
Amsacrine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000781	0.00231	CcSEcCtD
Amsacrine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00078	0.00231	CcSEcCtD
Amsacrine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000778	0.00231	CcSEcCtD
Amsacrine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000776	0.0023	CcSEcCtD
Amsacrine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000775	0.0023	CcSEcCtD
Amsacrine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000775	0.0023	CcSEcCtD
Amsacrine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000774	0.0023	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000772	0.00229	CcSEcCtD
Amsacrine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000771	0.00229	CcSEcCtD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—TGFB1—chronic obstructive pulmonary disease	0.000766	0.00927	CbGpPWpGaD
Amsacrine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000765	0.00227	CcSEcCtD
Amsacrine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000759	0.00225	CcSEcCtD
Amsacrine—NCOA3—Metabolism—APIP—chronic obstructive pulmonary disease	0.000754	0.00912	CbGpPWpGaD
Amsacrine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000753	0.00223	CcSEcCtD
Amsacrine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000753	0.00223	CcSEcCtD
Amsacrine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000749	0.00222	CcSEcCtD
Amsacrine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000749	0.00222	CcSEcCtD
Amsacrine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000749	0.00222	CcSEcCtD
Amsacrine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000749	0.00222	CcSEcCtD
Amsacrine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000747	0.00221	CcSEcCtD
Amsacrine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000746	0.00221	CcSEcCtD
Amsacrine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00074	0.00219	CcSEcCtD
Amsacrine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000739	0.00219	CcSEcCtD
Amsacrine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000739	0.00219	CcSEcCtD
Amsacrine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000737	0.00219	CcSEcCtD
Amsacrine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000737	0.00219	CcSEcCtD
Amsacrine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000735	0.00218	CcSEcCtD
Amsacrine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000735	0.00218	CcSEcCtD
Amsacrine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000734	0.00218	CcSEcCtD
Amsacrine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000734	0.00218	CcSEcCtD
Amsacrine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000731	0.00217	CcSEcCtD
Amsacrine—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000729	0.00882	CbGpPWpGaD
Amsacrine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000726	0.00215	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000723	0.00875	CbGpPWpGaD
Amsacrine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000722	0.00214	CcSEcCtD
Amsacrine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000719	0.00213	CcSEcCtD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—TNF—chronic obstructive pulmonary disease	0.000716	0.00866	CbGpPWpGaD
Amsacrine—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000713	0.00862	CbGpPWpGaD
Amsacrine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000711	0.00211	CcSEcCtD
Amsacrine—TOP2A—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.000709	0.0975	CbGdCrCtD
Amsacrine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000707	0.0021	CcSEcCtD
Amsacrine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000707	0.0021	CcSEcCtD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—chronic obstructive pulmonary disease	0.000705	0.00853	CbGpPWpGaD
Amsacrine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000698	0.00207	CcSEcCtD
Amsacrine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000698	0.00207	CcSEcCtD
Amsacrine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000697	0.00207	CcSEcCtD
Amsacrine—TOP2A—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.000692	0.0952	CbGdCrCtD
Amsacrine—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000686	0.00829	CbGpPWpGaD
Amsacrine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000684	0.00203	CcSEcCtD
Amsacrine—TOP2A—Gastric Cancer Network 2—EGFR—chronic obstructive pulmonary disease	0.000682	0.00825	CbGpPWpGaD
Amsacrine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000681	0.00824	CbGpPWpGaD
Amsacrine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00068	0.00202	CcSEcCtD
Amsacrine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00068	0.00202	CcSEcCtD
Amsacrine—KCNH2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000677	0.00819	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—EGFR—chronic obstructive pulmonary disease	0.000669	0.00809	CbGpPWpGaD
Amsacrine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000666	0.00197	CcSEcCtD
Amsacrine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000659	0.00195	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000653	0.0079	CbGpPWpGaD
Amsacrine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000648	0.00192	CcSEcCtD
Amsacrine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000648	0.00192	CcSEcCtD
Amsacrine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000645	0.00191	CcSEcCtD
Amsacrine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000642	0.0019	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—NOS3—chronic obstructive pulmonary disease	0.000639	0.00773	CbGpPWpGaD
Amsacrine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000635	0.00188	CcSEcCtD
Amsacrine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000626	0.00186	CcSEcCtD
Amsacrine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000626	0.00186	CcSEcCtD
Amsacrine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000614	0.00182	CcSEcCtD
Amsacrine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000612	0.00181	CcSEcCtD
Amsacrine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000602	0.00179	CcSEcCtD
Amsacrine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000602	0.00179	CcSEcCtD
Amsacrine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000597	0.00177	CcSEcCtD
Amsacrine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000597	0.00177	CcSEcCtD
Amsacrine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000597	0.00177	CcSEcCtD
Amsacrine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000597	0.00177	CcSEcCtD
Amsacrine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000597	0.00177	CcSEcCtD
Amsacrine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000593	0.00176	CcSEcCtD
Amsacrine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000593	0.00176	CcSEcCtD
Amsacrine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000593	0.00176	CcSEcCtD
Amsacrine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000592	0.00176	CcSEcCtD
Amsacrine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000592	0.00175	CcSEcCtD
Amsacrine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00059	0.00175	CcSEcCtD
Amsacrine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000585	0.00173	CcSEcCtD
Amsacrine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000585	0.00173	CcSEcCtD
Amsacrine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000581	0.00172	CcSEcCtD
Amsacrine—TOP2A—Gastric Cancer Network 2—TP53—chronic obstructive pulmonary disease	0.000573	0.00693	CbGpPWpGaD
Amsacrine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000569	0.00169	CcSEcCtD
Amsacrine—ABCB1—lung—chronic obstructive pulmonary disease	0.000568	0.013	CbGeAlD
Amsacrine—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000565	0.00684	CbGpPWpGaD
Amsacrine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000564	0.00167	CcSEcCtD
Amsacrine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000563	0.00167	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000563	0.00681	CbGpPWpGaD
Amsacrine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000563	0.00167	CcSEcCtD
Amsacrine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000563	0.00167	CcSEcCtD
Amsacrine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00056	0.00166	CcSEcCtD
Amsacrine—TOP2A—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000552	0.00668	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000552	0.00667	CbGpPWpGaD
Amsacrine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000551	0.00163	CcSEcCtD
Amsacrine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000545	0.00162	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000537	0.0065	CbGpPWpGaD
Amsacrine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000534	0.00158	CcSEcCtD
Amsacrine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000531	0.00158	CcSEcCtD
Amsacrine—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.00053	0.00641	CbGpPWpGaD
Amsacrine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000527	0.00156	CcSEcCtD
Amsacrine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000525	0.00156	CcSEcCtD
Amsacrine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000516	0.00153	CcSEcCtD
Amsacrine—TOP2A—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000507	0.00613	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000505	0.00611	CbGpPWpGaD
Amsacrine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000501	0.00148	CcSEcCtD
Amsacrine—NCOA3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000499	0.00604	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000495	0.00599	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000487	0.00589	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GC—chronic obstructive pulmonary disease	0.000486	0.00588	CbGpPWpGaD
Amsacrine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000476	0.00141	CcSEcCtD
Amsacrine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000469	0.00139	CcSEcCtD
Amsacrine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000464	0.00138	CcSEcCtD
Amsacrine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000461	0.00137	CcSEcCtD
Amsacrine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00046	0.00136	CcSEcCtD
Amsacrine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000457	0.00135	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000453	0.00547	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000452	0.00546	CbGpPWpGaD
Amsacrine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000439	0.0013	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000438	0.0053	CbGpPWpGaD
Amsacrine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00043	0.00128	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000425	0.00514	CbGpPWpGaD
Amsacrine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000423	0.00125	CcSEcCtD
Amsacrine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000422	0.00125	CcSEcCtD
Amsacrine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000417	0.00504	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—EGFR—chronic obstructive pulmonary disease	0.000414	0.00501	CbGpPWpGaD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—chronic obstructive pulmonary disease	0.000413	0.00499	CbGpPWpGaD
Amsacrine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000408	0.00121	CcSEcCtD
Amsacrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000407	0.00493	CbGpPWpGaD
Amsacrine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000402	0.00486	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.0004	0.00484	CbGpPWpGaD
Amsacrine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000396	0.00117	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000391	0.00473	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000388	0.00469	CbGpPWpGaD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000386	0.00115	CcSEcCtD
Amsacrine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000378	0.00112	CcSEcCtD
Amsacrine—Infection—Prednisone—chronic obstructive pulmonary disease	0.00037	0.0011	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000368	0.00445	CbGpPWpGaD
Amsacrine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000364	0.00108	CcSEcCtD
Amsacrine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000362	0.00107	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.00036	0.00435	CbGpPWpGaD
Amsacrine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000355	0.00105	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.00035	0.00423	CbGpPWpGaD
Amsacrine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000339	0.00101	CcSEcCtD
Amsacrine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000335	0.000993	CcSEcCtD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00033	0.00399	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.00033	0.00399	CbGpPWpGaD
Amsacrine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000324	0.000961	CcSEcCtD
Amsacrine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000323	0.000959	CcSEcCtD
Amsacrine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000323	0.000958	CcSEcCtD
Amsacrine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000321	0.000953	CcSEcCtD
Amsacrine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000321	0.000953	CcSEcCtD
Amsacrine—TOP2A—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000315	0.00381	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000311	0.00376	CbGpPWpGaD
Amsacrine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000307	0.000911	CcSEcCtD
Amsacrine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000305	0.000904	CcSEcCtD
Amsacrine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000305	0.000904	CcSEcCtD
Amsacrine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000296	0.000878	CcSEcCtD
Amsacrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000296	0.00358	CbGpPWpGaD
Amsacrine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000295	0.000874	CcSEcCtD
Amsacrine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000295	0.000874	CcSEcCtD
Amsacrine—TOP2A—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000293	0.00355	CbGpPWpGaD
Amsacrine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000292	0.00353	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000285	0.00345	CbGpPWpGaD
Amsacrine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000275	0.000815	CcSEcCtD
Amsacrine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000267	0.000793	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000266	0.00322	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000265	0.00321	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000262	0.00317	CbGpPWpGaD
Amsacrine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000255	0.000756	CcSEcCtD
Amsacrine—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000254	0.00307	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000253	0.00306	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.000251	0.00303	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000247	0.00299	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000247	0.00299	CbGpPWpGaD
Amsacrine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000247	0.000731	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000245	0.00296	CbGpPWpGaD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00024	0.0029	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000239	0.0029	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000237	0.00287	CbGpPWpGaD
Amsacrine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000237	0.000703	CcSEcCtD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000235	0.00285	CbGpPWpGaD
Amsacrine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000235	0.000697	CcSEcCtD
Amsacrine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000235	0.000696	CcSEcCtD
Amsacrine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000234	0.000693	CcSEcCtD
Amsacrine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000221	0.000657	CcSEcCtD
Amsacrine—NCOA3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000221	0.00267	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000211	0.00255	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.00021	0.00254	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000209	0.00252	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000201	0.00243	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000198	0.0024	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000189	0.00228	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000184	0.00222	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000181	0.00219	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000177	0.00214	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.00212	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	0.000173	0.0021	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000173	0.00209	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000172	0.00208	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—EGFR—chronic obstructive pulmonary disease	0.00017	0.00205	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000169	0.00204	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000162	0.00196	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—TNF—chronic obstructive pulmonary disease	0.000162	0.00196	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.00194	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000159	0.00193	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000152	0.00183	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000146	0.00177	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	0.000145	0.00176	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000144	0.00175	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.000139	0.00169	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000139	0.00168	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000136	0.00165	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000134	0.00163	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000134	0.00162	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000133	0.0016	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—IL6—chronic obstructive pulmonary disease	0.000131	0.00158	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000128	0.00155	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00154	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.00152	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	0.000118	0.00143	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000117	0.00142	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ALB—chronic obstructive pulmonary disease	0.000109	0.00132	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000109	0.00132	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	0.000108	0.00131	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000104	0.00126	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	0.000103	0.00124	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	0.000101	0.00122	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.21e-05	0.000872	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	7.01e-05	0.000848	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.79e-05	0.000822	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	6.61e-05	0.000799	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.52e-05	0.000789	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.14e-05	0.000743	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.83e-05	0.000705	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TP53—chronic obstructive pulmonary disease	5.79e-05	0.0007	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.59e-05	0.000676	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	5.35e-05	0.000647	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.24e-05	0.000634	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.99e-05	0.000604	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.4e-05	0.000533	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.83e-05	0.000463	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.79e-05	0.000458	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.61e-05	0.000437	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	3.57e-05	0.000432	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.46e-05	0.000418	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.36e-05	0.000406	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	3.26e-05	0.000394	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.18e-05	0.000385	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3e-05	0.000363	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.66e-05	0.000321	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.62e-05	0.000317	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.5e-05	0.000303	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.47e-05	0.000299	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.44e-05	0.000295	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.31e-05	0.00028	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.3e-05	0.000278	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.18e-05	0.000264	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.57e-05	0.00019	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.5e-05	0.000182	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	1.48e-05	0.000179	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.42e-05	0.000171	CbGpPWpGaD
